Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $4,393,000.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 230,000 shares of the firm's stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $19.10, for a total transaction of $4,393,000.00. Following the transaction, the president now directly owns 2,132,899 shares of the company's stock, valued at $40,738,370.90. This represents a 9.73 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, March 27th, Dawn Christine Maroney sold 11,152 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.89, for a total value of $199,509.28.
• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.40, for a total value of $271,174.00.
• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.99, for a total transaction of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total value of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total value of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total value of $411,600.00.

Alignment Healthcare Trading Down 6.4 %

Shares of ALHC stock traded down $1.24 during trading hours on Friday, reaching $18.24. 6,294,406 shares of the stock were exchanged, compared to its average volume of 1,678,380. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a 12-month low of $4.92 and a 12-month high of $21.06. The firm has a market capitalization of $3.50 billion, a price-to-earnings ratio of -23.69 and a beta of 1.32. The company's 50-day moving average price is $16.54 and its 200-day moving average price is $13.84.

Wall Street Analysts Forecast Growth

ALHC has been the subject of a number of recent analyst reports. Robert W. Baird upped their price target on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research report on Tuesday. JPMorgan Chase & Co. raised their price target on Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a report on Thursday, March 6th. Piper Sandler increased their target price on Alignment Healthcare from $14.00 to $21.00 and gave the stock an "overweight" rating in a research report on Tuesday, March 4th. Stifel Nicolaus upped their price target on Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research note on Tuesday, April 8th. Finally, Barclays boosted their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Alignment Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $16.61.

Hedge Funds Weigh In On Alignment Healthcare

Hedge funds have recently bought and sold shares of the business. R Squared Ltd bought a new position in shares of Alignment Healthcare in the fourth quarter worth about $55,000. RiverPark Advisors LLC purchased a new position in shares of Alignment Healthcare in the fourth quarter worth about $106,000. Tower Research Capital LLC TRC boosted its holdings in Alignment Healthcare by 146.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after purchasing an additional 6,286 shares during the last quarter. Ballentine Partners LLC purchased a new stake in Alignment Healthcare during the fourth quarter worth $121,000. Finally, Aigen Investment Management LP acquired a new stake in Alignment Healthcare in the fourth quarter valued at approximately $129,000. Institutional investors own 86.19% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.